Studies have shown that MX2 mRNA is elevated in COVID-19 patients, both in nasopharyngeal swabs36 and in BALF of mild cases but not severe cases37, suggesting that an early induction of MX2 is associated with milder infection. Here, MX2 is linked to COVID-19.